Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses

When developing drugs against SARS-CoV-2, it is important to consider the characteristics of patients with different co-morbidities. People infected with HIV-1 are a particularly vulnerable group, as they may be at a higher risk than the general population of contracting COVID-19 with clinical compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Fomenko, Vladislav V., Rudometova, Nadezhda B., Yarovaya, Olga I., Rogachev, Artem D., Fando, Anastasia A., Zaykovskaya, Anna V., Komarova, Nina I., Shcherbakov, Dmitry N., Pyankov, Oleg V., Pokrovsky, Andrey G., Karpenko, Larisa I., Maksyutov, Rinat A., Salakhutdinov, Nariman F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746574/
https://www.ncbi.nlm.nih.gov/pubmed/35011529
http://dx.doi.org/10.3390/molecules27010295